David E I Pyott insider trades
Open-market stock purchases and sales by David E I Pyott, Director at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 18, 2010.
Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -6%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $351K |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $274K |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $366K |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $149K |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $5.1K |
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Apr 24, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 18, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 18, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- TARS Tarsus Pharmaceuticals, Inc: other filings, last Sep 15, 2026
- ALNY Alnylam Pharmaceuticals, Inc: 1 buy, 9 sales, last Jun 1, 2026
- PLRX Pliant Therapeutics, Inc: other filings, last Jun 5, 2025
- BMRN Biomarin Pharmaceutical Inc: 2 buys, last May 21, 2024
- AVY Avery Dennison Corp: 6 sales, last Apr 23, 2020
- AGN Allergan Inc: 11 sales, last Mar 17, 2015
- EW Edwards Lifesciences Corp: 1 buy, 6 sales, last May 9, 2014